Article
Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects
1 Jan 2023
Abstract excerpt
The emergence of chemoresistant disease during chemotherapy with 5-Fluorouracil-based (5-FU-based) regimens is an important factor in the mortality of metastatic CRC (mCRC). The causes of 5-FU resistance are multi-factorial, and besides DNA mismatch repair deficiency (MMR-D), there are no widely accepted criteria for determining which CRC patients are not likely to be responsive to 5-FU-based therapy. Thus, there...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
